Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-Criteria Decision Analysis of Biologics in Chronic Obstructive Pulmonary Disease.

International journal of chronic obstructive pulmonary disease - 1 Jan 2025

Matera Maria Gabriella, Calzetta Luigino, Rogliani Paola, Cazzola Mario

Abstract excerpt

Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with limited response to standard anti-inflammatory therapies. Biologics targeting specific inflammatory pathways have emerged as potential treatments, but their efficacy remains variable across distinct COPD endotypes. Objective: To systematically evaluate the efficacy and trial quality of biologics tested in COPD patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Biological Products

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clinical Decision-Making

Share to Decision Support Techniques

Share to Inflammation Mediators

Share to Pulmonary Disease, Chronic Obstructive

Share to Recovery of Function

Share to Research Design

Source

Open in PubMed Open full text

Identifiers

PMID: 40955382
DOI: 10.2147/COPD.S550144
PMCID: PMC12433631

Genes

TNF
TSLP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 26 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Multi-Criteria Decision Analysis of Biologics in Chronic Obstructive Pulmonary Disease.PMID 40955382Read ↗

Viewpoint: Pathway-sensitive eligibility for biologic therapy in COPD: The role of primary care, phenotyping, and eosinophil-guided management.Semantic proximity Read ↗

Safety Analysis of Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Real-World Study Based on the FAERS DatabaseSemantic proximity Read ↗

Efficacy of Biologics in Aspirin Exacerbated Respiratory Disease: A Narrative ReviewSemantic proximity Read ↗

¿p#1 Multidomain Clinical and Biological Remission with Tezepelumab in Severe Asthma: A 12-Month Multicentre Real-World StudySemantic proximity Read ↗

Towards Optimum Reporting of Pulmonary Effectiveness Databases and Outcomes (TORPEDO): identifying a core dataset for asthma and COPD studiesSemantic proximity Read ↗

Benefit-Risk Assessment of Medical Products Using Bayesian Multi-Criteria Augmented Decision Analysis for Clinical DevelopmentSemantic proximity Read ↗

Procalcitonin-Guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations (PRECISION): Study Protocol for a Prospective Randomized Controlled Trial.Semantic proximity Read ↗

Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis.Semantic proximity Read ↗

Dual Bronchodilation with Tiotropium/Olodaterol: A Revised Cost-Utility Analysis for COPD in ColombiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.